Scientists knew that obesity raises the risk of hypertension. Now Paul Cohen's team has uncovered the mechanism—and the enzyme—that explains how fat can stiffen blood vessels and drive blood pressure upward.

New study shows that beige fat suppresses an enzyme that promotes high blood pressure, revealing a new molecular pathway and a potential target for future precision therapies.

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

Researchers discovered new characteristics of a T cell receptor that’s essential to a variety of cutting-edge T cell immunotherapies.

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Replicative aging of human cells, the result of telomere shortening, is slower at physiological oxygen than at atmospheric oxygen, a difference now shown to be due to low oxygen impairing the ATM kinase response to withered telomeres.

The discovery could greatly improve patient experience and address supply shortages.

Boosting PI31 has been shown to head off Parkinson’s-like disorders and extend lifespan in fruit flies and mice, pointing to a possible new therapeutic target for treating rare neurodegenerative diseases, as well as more common disorders, such as Alzheimer's.

Researchers have learned that the antioxidant glutathione, when operating inside mitochondria, is a key factor enabling tumors to spread from the breast to the lung.

After nearly a decade of cataloguing evolutionarily young genes, complementary studies are the first to demonstrate how they are regulated and expressed.
View
View